| Product Code: ETC348261 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China Structural Heart Devices Market was estimated at USD 260 Million in 2025 and is projected to reach USD 341 Million by 2032, growing at a CAGR of 4.0% from 2026 to 2032. This growth trajectory is primarily driven by the escalating prevalence of cardiovascular diseases in the region, coupled with a rapidly aging population that necessitates advanced treatment options. Furthermore, the shift towards minimally invasive procedures is enhancing the demand for structural heart devices, leading to a transformative impact on patient care in China.
This graph highlights how the China Structural Heart Devices Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.0% | decrease in healthcare investments |
| 2022 | 7.5% | rise in patient treatment options |
| 2023 | -0.5% | slowdown in market penetration |
| 2024 | 5.6% | increased government funding initiatives |
| 2025 | 4.6% | growth in aging population demand |
| 2026 | 6.7% | expansion of innovative technologies |
| 2027 | 5.5% | enhanced healthcare infrastructure investments |
| 2028 | 5.5% | surge in patient awareness campaigns |
| 2029 | 5.6% | increased production capacity utilization |
| 2030 | 5.9% | rising prevalence of chronic conditions |
| 2031 | 6.1% | development of advanced training programs |
| 2032 | 6.0% | stronger distribution network expansion |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
In China, the rising incidence of heart-related ailments has significantly propelled the adoption of structural heart devices, including transcatheter heart valves and occluders. The efficacy of these devices in providing effective treatment alternatives with reduced recovery times is attracting both healthcare professionals and patients alike.
Furthermore, advancements in technology are fostering innovation within the sector, resulting in improved product offerings that cater to the diverse needs of patients. As healthcare infrastructure continues to develop, the accessibility of these advanced medical devices is also increasing, allowing for broader market penetration.
Despite the promising growth, the China Structural Heart Devices Market faces specific restraints that may hinder its full potential. Regulatory complexities can slow the approval process for new devices, making it challenging for manufacturers to introduce innovations swiftly. Additionally, there exists a significant gap in awareness regarding the benefits of these devices, both among healthcare providers and patients, which can lead to hesitation in adoption. Addressing these issues through effective education and streamlined regulatory processes will be critical to unlocking the market's full potential.
The market is witnessing a notable trend toward innovative, minimally invasive treatments, particularly in the area of Transcatheter Aortic Valve Replacement (TAVR). These procedures are becoming preferred alternatives to traditional surgeries, as they offer lower risks and quicker recovery. Additionally, the rising interest in atrial septal defect closure and left atrial appendage closure devices showcases a shift towards targeted therapies for specific heart conditions. Moreover, market players are increasingly focusing on strategic partnerships and collaborations to enhance their technological capabilities and product offerings.
There are significant investment opportunities in the China Structural Heart Devices Market, particularly in segments like TAVR, left atrial appendage closure (LAAC), and transcatheter mitral valve repair (TMVR) devices. As the healthcare infrastructure improves and the population ages, these segments are expected to grow substantially. Investors can benefit from aligning with local manufacturers, tapping into existing distribution networks, and staying attuned to evolving regulatory developments to maximize their market presence.
The Chinese government has introduced various initiatives to stimulate growth in the Structural Heart Devices Market. These include stringent product registration processes, quality control standards, and reimbursement frameworks designed to enhance patient safety and promote technological innovation. Public funding initiatives aimed at supporting domestic manufacturers are also in place, aimed at fostering a more competitive environment while ensuring that advancements meet the highest safety standards.
Looking ahead to 2026-2032, the China Structural Heart Devices Market is poised for robust growth driven by demographic shifts and technological advancements. The increasing prevalence of cardiovascular diseases among the aging population will continue to amplify the demand for minimally invasive treatment options. Coupled with ongoing government support to enhance healthcare access, the market stands to benefit from an expanding middle class with greater disposable incomes, fueling both demand and investment opportunities.
Recent developments within the China Structural Heart Devices Market indicate a strong focus on innovation, with several manufacturers exploring new materials and technologies to enhance device performance and patient outcomes. Collaborative ventures between domestic firms and international entities are also on the rise, aiming to leverage shared expertise and resources. Furthermore, ongoing clinical trials are contributing to expanding the evidence base for various devices, potentially leading to new approvals and market expansions in the near future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Structural Heart Devices Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Structural Heart Devices Market Revenues & Volume, 2022 & 2032F |
3.3 China Structural Heart Devices Market - Industry Life Cycle |
3.4 China Structural Heart Devices Market - Porter's Five Forces |
3.5 China Structural Heart Devices Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 China Structural Heart Devices Market Revenues & Volume Share, By Procedure, 2022 & 2032F |
4 China Structural Heart Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in China |
4.2.2 Growing adoption of minimally invasive procedures |
4.2.3 Technological advancements in structural heart devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of structural heart devices in China |
4.3.2 High cost associated with structural heart procedures |
4.3.3 Lack of skilled healthcare professionals in the field of structural heart interventions |
5 China Structural Heart Devices Market Trends |
6 China Structural Heart Devices Market, By Types |
6.1 China Structural Heart Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Structural Heart Devices Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 China Structural Heart Devices Market Revenues & Volume, By Herat Valve Devices, 2022-2032F |
6.1.4 China Structural Heart Devices Market Revenues & Volume, By Surgical Heart Valves, 2022-2032F |
6.1.5 China Structural Heart Devices Market Revenues & Volume, By Transcatheter Heart Valves, 2022-2032F |
6.1.6 China Structural Heart Devices Market Revenues & Volume, By Occluders and Delivery Systems, 2022-2032F |
6.1.7 China Structural Heart Devices Market Revenues & Volume, By Annuloplasty Rings, 2022-2032F |
6.1.8 China Structural Heart Devices Market Revenues & Volume, By Other Devices, 2022-2032F |
6.2 China Structural Heart Devices Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 China Structural Heart Devices Market Revenues & Volume, By Replacement Procedures, 2022-2032F |
6.2.3 China Structural Heart Devices Market Revenues & Volume, By TAVR Procedures, 2022-2032F |
6.2.4 China Structural Heart Devices Market Revenues & Volume, By SAVR Procedures, 2022-2032F |
6.2.5 China Structural Heart Devices Market Revenues & Volume, By Repair Procedures, 2022-2032F |
6.2.6 China Structural Heart Devices Market Revenues & Volume, By Closure Procedures, 2022-2032F |
6.2.7 China Structural Heart Devices Market Revenues & Volume, By Annuloplasty, 2022-2032F |
6.2.8 China Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2022-2032F |
6.2.9 China Structural Heart Devices Market Revenues & Volume, By TMVR Procedures, 2022-2032F |
7 China Structural Heart Devices Market Import-Export Trade Statistics |
7.1 China Structural Heart Devices Market Export to Major Countries |
7.2 China Structural Heart Devices Market Imports from Major Countries |
8 China Structural Heart Devices Market Key Performance Indicators |
8.1 Number of hospitals offering structural heart procedures in China |
8.2 Adoption rate of new structural heart devices in the market |
8.3 Number of clinical trials for structural heart devices conducted in China |
9 China Structural Heart Devices Market - Opportunity Assessment |
9.1 China Structural Heart Devices Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 China Structural Heart Devices Market Opportunity Assessment, By Procedure, 2022 & 2032F |
10 China Structural Heart Devices Market - Competitive Landscape |
10.1 China Structural Heart Devices Market Revenue Share, By Companies, 2025 |
10.2 China Structural Heart Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here